1. Home
  2. Business & Finance
  3. Biotech / Biomedical
Theresa Phillips
Theresa's Biotech / Biomedical Blog

By Theresa Phillips, About.com Guide to Biotech / Biomedical

Weak Patent System a Public Health Risk

Thursday June 18, 2009

How does a weak patent system affect ordinary people? There's more to IP laws than protecting companies so they can make a profit. Of course part of building a strong intellectual property rights (IPR) system is supporting businesses within your jurisdiction (i.e. country) but that doesn't necessarily apply if the business in question of part of big pharma. So how does protecting the interests of even the big companies help us?

    Startup Financing – Smaller companies benefit from ood IPR legislation because, if their discoveries are protected, they are more likely to have one of the key criteria among what venture investors are looking for, security for the future. This makes it easier to obtain venture funding to take their products to market.
    Legal Empowerment – Why create laws that border officials and law enforcement officers can't enforce? This is part of having a strong IPR system that might be easily overlooked. The laws protecting IP need to come hand-in-hand with strong enforcement practices and adequate consequences to deter non-compliance.
    Public Safety – How many of us wouldn't buy the "generic" brand to save a little cash? Counterfeit drugs are everywhere. Preventing knock-off drugs, whether imported or domestic, that might not contain the proper ingredients, or have the right stuff mixed in the wrong amounts is important to public protection.

Comments

No comments yet. Leave a Comment

Leave a Comment

Line and paragraph breaks are automatic. Some HTML allowed: <a href="" title="">, <b>, <i>, <strike>

Explore Biotech / Biomedical
About.com Special Features

10 Things You Can Do Today to Improve Your Credit

Easy steps to take control of your credit card debt. More >

Year End Tax Planning

Discover financial planning opportunities with these three tips. More >

  1. Home
  2. Business & Finance
  3. Biotech / Biomedical

©2010 About.com, a part of The New York Times Company.

All rights reserved.